Although no significant correlation was found for PR status, breast cancers that were both ER+/PR+, were again more likely to be GRM1+, compared to cancers that were ER−/PR- (O.R. 2.3, 95% CI [1.3-4.5], p = 0.009). This evidence concerns the gene GRM1 and breast cancer.